Table 2.
Variable | Poor Memory | Word‐Finding Difficulty | Poor Concentration | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
95% CI | 95% CI | 95% CI | ||||||||||
OR | lower | upper | P value | OR | lower | upper | P value | OR | lower | upper | P value | |
Physically activeb | 0.83 | 0.72 | 0.96 | 0.01* | 0.45 | 0.30 | 0.67 | 0.0001* | 0.82 | 0.77 | 0.87 | <0.0001* |
Anti‐TNF use | 0.69 | 0.53 | 0.90 | 0.01* | 1.14 | 0.71 | 1.83 | 0.58 | 0.75 | 0.54 | 1.06 | 0.10 |
DAS28‐CRP3 | 1.07 | 0.98 | 1.17 | 0.14 | 1.02 | 0.91 | 1.13 | 0.78 | 1.07 | 0.99 | 1.17 | 0.09 |
Gender (female) | 2.67 | 0.80 | 8.90 | 0.11 | 1.21 | 0.46 | 3.22 | 0.70 | 4.88 | 1.13 | 21.12 | 0.03* |
Depression score (MHI‐D) | 0.99 | 0.90 | 1.09 | 0.82 | 1.05 | 0.97 | 1.14 | 0.22 | 0.97 | 0.92 | 1.02 | 0.24 |
Methotrexate use | 0.83 | 0.60 | 1.16 | 0.28 | 0.78 | 0.51 | 1.19 | 0.25 | 1.06 | 0.77 | 1.45 | 0.72 |
Corticosteroid use | 0.92 | 0.62 | 1.37 | 0.69 | 0.99 | 0.62 | 1.56 | 0.95 | 1.22 | 0.96 | 1.54 | 0.11 |
BMI | 1.00 | 0.96 | 1.04 | 0.82 | 1.00 | 0.96 | 1.03 | 0.92 | 0.98 | 0.93 | 1.03 | 0.46 |
Education (college degree or more) | 0.83 | 0.44 | 1.55 | 0.55 | 0.83 | 0.42 | 1.66 | 0.60 | 0.84 | 0.41 | 1.72 | 0.63 |
Sleep difficulties (MDHAQ) | 1.09 | 0.82 | 1.45 | 0.54 | 0.99 | 0.77 | 1.26 | 0.92 | 1.09 | 0.92 | 1.28 | 0.31 |
Fatigue (VAS) | 1.00 | 0.99 | 1.01 | 0.70 | 1.00 | 1.00 | 1.01 | 0.70 | 1.00 | 0.99 | 1.00 | 0.36 |
Age, y | 1.00 | 0.98 | 1.02 | 1.00 | 1.00 | 0.97 | 1.02 | 0.78 | 0.99 | 0.97 | 1.01 | 0.48 |
Abbreviation: CI, confidence interval; DAS28‐CRP, Disease Activity Score 28 joints–c‐reactive protein; MDHAQ, Multidimensional Health Assessment Questionnaire; MHI‐D, Mental Health Index‐Depression; OR, odds ratio; TNF, tumor necrosis factor; VAS, visual analog scale.
aAdjusted for time (days) between questionnaires. bMeeting the US Department of Health and Human Services recommendation for physical activity.
P < 0.05.